title: Utility of capsule endoscopy for evaluating anthelmintic efficacy in fully conscious dogs.
abstract: The current accepted standard for evaluating the efficacy of gastrointestinal anthelmintic drugs is necropsy of infected animals followed by a comparison of worm counts between treated and non-treated groups. In this study capsule endoscopy, a minimally invasive method of imaging the small intestine of humans, is evaluated as a possible alternative to necropsy for the purposes of worm quantification in dogs. Eighteen Beagle dogs were included in this study. These dogs were part of a separate trial intended to determine the efficacy of various candidate parasiticides against Ancylostoma caninum via the necropsy standard. Dogs were inoculated with A. caninum L3s 4 weeks prior to treatment with one of the candidate compounds; a control group (n=8) received no treatment. Capsule endoscopy was performed 6-14 days post-treatment, followed by necropsy the following day. Seventeen dogs had complete examinations, i.e. the capsule traversed the small intestine and reached the colon within the battery life of the capsule. A strong correlation (r(s)=0.87, P<0.0001) was observed between the worm counts acquired by capsule endoscopy and necropsy. There was no clear relationship between the ability of the capsule endoscope to detect hookworms and either visibility of the intestinal lumen or small intestinal transit time. Generation of a virtual spatial record of hookworm location from the capsule endoscopy data revealed a temporal trend, with the majority of worms present in the proximal small intestine in the morning versus the central to distal small intestine in the afternoon. Worm distribution as determined by capsule endoscopy closely resembled post-mortem findings. In conclusion, capsule endoscopy shows promise as an alternative to necropsy for the enumeration of A. caninum in the canine small intestine, although further work is required to improve completion rates and optimise intestinal examination.
authors.affiliation: Department of Microbiology & Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA. cl568@cornell.edu
authors.forename: Alice C Y
authors.initials: AC
authors.lastname: Lee
authors.forename: Christian
authors.initials: C
authors.lastname: Epe
authors.forename: Kenneth W
authors.initials: KW
authors.lastname: Simpson
authors.forename: Dwight D
authors.initials: DD
authors.lastname: Bowman
mesh_terms: D000722:Ancylostoma / Q000187:drug effects* / Q000502:physiology; D000724:Ancylostomiasis / Q000175:diagnosis / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary*; D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage*; D053704:Capsule Endoscopy / Q000379:methods* / Q000662:veterinary; D004283:Dog Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000469:parasitology; D004285:Dogs; D016903:Drug Monitoring / Q000295:instrumentation / Q000379:methods* / Q000662:veterinary; D005260:Female; D007410:Intestinal Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary; D008297:Male
chemical_list: D000871:Anthelmintics